About Editorial team of BIPNs

Main team of content of bipns.com. Any type of content should be approved by us.
9 10, 2025

Binance Coin (BNB) Price Analysis for October 9

By |2025-10-09T18:04:47+03:00October 9, 2025|Crypto News, News|0 Comments

Sellers are trying to seize the initiative, according to CoinStats.

BNB chart by CoinStats

BNB/USD

The rate of Binance Coin (BNB) has gone down by almost 2% since yesterday.

Article image
Image by TradingView

On the hourly chart, the price of BNB is declining after a false breakout of the local resistance of $1,318. If bulls cannot come back to the game, there is a high chance to see a test of the $1,252 level by tomorrow.

Article image
Image by TradingView

On the longer time frame, the rate of the native exchange coin is far from key levels. In this case, one should pay attention to the bar closure in terms of yesterday’s candle’s low. 

You Might Also Like

Title news

If it happens near it or below, the drop is likely to continue to the $1,200 range.

Article image
Image by TradingView

From the midterm point of view, there are no reversal signals yet. In this regard, traders should focus on the weekly bar’s closure in terms of its peak. If it happens with a short wick, the upward move may lead to the test of a new all-time high.

BNB is trading at $1,271 at press time.

Source link

9 10, 2025

Qué son los biosimilares: Un mejor acceso a medicamentos avanzados

By |2025-10-09T17:45:43+03:00October 9, 2025|Fitness News, News|0 Comments


English

El término “biosimilares” suena como algo de una novela de ciencia ficción, pero afortunadamente son avances reales de la medicina. Pero, para entenderlos mejor, primero debemos comprender un tipo de medicamentos denominados biofármacos. Retrocedamos un poco.

La mayoría de medicamentos que las personas toman son fármacos de moléculas pequeñas, lo que significa que tienen una estructura química simple y su preparación es relativamente fácil. Incluyen muchos medicamentos comunes tales como aspirinas y antibióticos.

Los biofármacos son un tipo diferente y más nuevo de medicamentos que están compuestos por macromoléculas grandes y orgánicas, usualmente proteínas. Son mucho más complejos que los fármacos de moléculas pequeñas. Ejemplos de biofármacos son inmunoterapias para tratar el cáncer, terapias con células madre para una variedad de trastornos complejos y vacunas para prevenir enfermedades infecciosas.

Qué son los biofármacos

Los biofármacos son medicamentos preparados a base de células vivas, piensa en proteínas tales como anticuerpos, hormonas, enzimas”, explicó Annie DePasquale, M.D., doctora de medicina familiar certificada y fundadora de Collaborating Docs. “Los medicamentos tradicionales (tales como la mayoría de comprimidos) son moléculas pequeñas sintetizadas químicamente para las cuales cada lote es idéntico. Los biofármacos se cultivan en sistemas vivos, así que son por naturaleza más variables y requieren controles de calidad extremadamente altos.

Piensa en eso de esta forma: Cada químico es como un componente. Si juntas varios componentes de cierta forma, obtendrás un fármaco de moléculas pequeñas. Cualquier persona que tenga los mismos componentes y los junte de la misma forma podrá preparar una copia exacta del original. Cuando esto se hace en el ámbito de fármacos de moléculas pequeñas, obtenemos medicamentos genéricos. Son copias exactas del original, iguales a medicamentos de marca, pero sin la marca, lo cual hace que resulten menos caros.

Los biofármacos son mucho más complicados. En vez de una estructura simple y compuesta por unas docenas de componentes químicos, estas macromoléculas tienen miles de piezas en una configuración muy compleja. La preparación de un biofármaco requiere mucho más que agregar cada elemento correctamente. Son compuestos orgánicos y deben prepararse en células vivas, usando tecnología de ADN.

Cuando preparas una copia de un biofármaco para incrementar el acceso a esta terapia, obtienes un biosimilar, una terapia que es igual de segura y efectiva que el tratamiento original. Sin embargo, hay diferencias estructurales. Imagina que es algo parecido a hornear pan. Puedes usar los mismos ingredientes y seguir la misma receta, pero cada pedazo de pan es un poco diferente. Las copias biosimilares de biofármacos no son precisamente idénticas a los originales, pero son muy similares. Lo importante es que tienen la misma seguridad y eficacia.

De biofármacos a biosimilares

Los genéricos nos dan acceso al mismo tratamiento a menor costo. Los biosimilares, al igual que los genéricos, hacen que ciertos tratamientos avanzados sean más asequibles y accesibles.

Los biofármacos son muy caros. Puede tomar más de 10 años y costar miles de millones de dólares en desarrollo de un solo biofármaco. Ese costo se transfiere a los pacientes y aseguradoras. “Incluso cuando varios competidores empiezan a producirlos, los biofármacos siguen siendo más costosos que la mayoría de píldoras, y es ahí donde los biosimilares son útiles para reducir costos”, dijo DePasquale.

Pero los biosimilares no son exactamente baratos: Su desarrollo también toma años y cuesta millones de dólares. Pero el costo total de desarrollo es mucho menor que el de un biofármaco original. Consecuentemente, su uso puede aprobarse más rápido y con menos gastos. Esta reducción de costo puede ser útil para solucionar algunas disparidades. Personas de grupos históricamente marginados, especialmente si tienen seguros públicos, son menos propensas a comprar los biofármacos indicados en sus recetas médicas. Con biosimilares más asequibles, más personas pueden beneficiarse de medicamentos avanzados.

Cómo se preparan los biosimilares

iStock.com/Alernon77

Al igual que los biofármacos, los biosimilares se preparan mediante un proceso complejo usando tecnología de ADN.

Primero, el código genético para una proteína específica se inserta en células vivas. Estas células podrían ser levadura o bacterias, así como células vegetales o animales. Las células “leen” el código como si fuese una receta y empiezan a producir cantidades importantes de proteínas Son como miles de millones de cocinas diminutas y orgánicas. Y tienen estándares altos. El entorno debe ser altamente controlado para que las condiciones sean adecuadas. Una vez que las células producen la proteína, se aísla y purifica para su uso como un medicamento biosimilar. Estos medicamentos pueden administrarse entonces a pacientes mediante inyecciones o infusiones IV.

Beneficios bioequivalentes

Entonces, ¿son los biosimilares tan seguros y efectivos como los biofármacos originales? La respuesta es sí. “La FDA [Administración de alimentos y medicamentos] evalúa rigurosamente los biosimilares usando un método en función de ‘toda la evidencia’”, dijo DePasquale. “Eso incluye pruebas analíticas para demostrar una alta similitud, estudios del comportamiento del medicamento en el cuerpo, evaluaciones de inmunogenia (el riesgo de que el cuerpo reaccione a la proteína) y al menos un estudio clínico para confirmar que no haya diferencias significativas”.

Un biosimilar debe tener características muy similares a las del biofármaco original (denominado producto de referencia) para que se considere bioequivalente:

  • Debe estar compuesto del mismo tipo de materiales naturales.
  • La estructura molecular debe ser muy similar a la del producto de referencia.
  • Su uso debe ser igual de seguro.
  • Debe proporcionar los mismos beneficios terapéuticos.
  • Debe tener la misma concentración y dosis.
  • Debe administrarse de la misma forma.

En otras palabras: Los biosimilares no tienen ninguna diferencia clínicamente significativa en comparación con los productos originales de referencia. Funcionan de la misma forma. Proporcionan los mismos beneficios. “En comparaciones entre los dos productos, los biosimilares tienen un desempeño equivalente al de los productos de referencia para los trastornos para los que se aprobaron los tratamientos”, dijo DePasquale. “Muchos pacientes han hecho el cambio de un biofármaco de referencia a un biosimilar sin ninguna pérdida de eficacia y sin problemas de seguridad nuevos”.

¿Qué tratan los biosimilares?

Los biofármacos y los biosimilares pueden tratar “una amplia gama de trastornos que [tienen un gran impacto en] las mujeres o que frecuentemente surgen durante la mediana edad”, explicó DePasquale:

Los biosimilares son medicamentos avanzados y pueden imitar procesos biológicos naturales del cuerpo. Se dirigen y adhieren a células específicas, interactúan con proteínas y bloquean o activan reacciones inmunitarias. Consecuentemente, son muy útiles para evitar que ciertas células hagan cosas que empeoren o propaguen trastornos. Con el menor costo y el mayor acceso de los biosimilares, más mujeres pueden recibir el mejor tratamiento posible para vivir las mejores versiones de sus vidas.

Este recurso educativo se preparó con el apoyo de Sandoz.

From Your Site Articles

Related Articles Around the Web



Source link

9 10, 2025

Copper price is paving the way for a new rise – Forecast today – 9-10-2025

By |2025-10-09T16:30:28+03:00October 9, 2025|Forex News, News|0 Comments


Copper price began today’s trading with a new positivity, attempting to breach the barrier at $5.0600 level, to confirm its surrender to the suggested bullish scenario.

 

We recommend waiting for confirming the activation of the price with the positivity of the main indicators by its rally towards $5.200 level, then attempt to press on the barrier at $5.3200, forming the initial main target of the current bullish track.

 

The expected trading range for today is between $4,988 and $5.2000

 

Trend forecast: Bullish





Source link

9 10, 2025

EURUSD Forecast Today – 09/10:Euro Continues to Struggle

By |2025-10-09T16:29:24+03:00October 9, 2025|Forex News, News|0 Comments

  • It looks like we are going to see yet another situation like we have seen over the last several days where the Euro gets sold off pretty early. But when the Americans show up, the United States dollar starts to shrink. And I think that is part of what’s going on here. American traders are just simply selling the US dollar.
  • That being said, the 1.16 level continues to offer support. And if we were to break down below that level, I think you’ve got a situation where we could really start to break down at that point, the market could drop to the 1.14 level, which of course is right about where the 200 day EMA is currently hanging around.

US Dollar Was Supposed to Collapse.

Remember, we were told that the US dollar was going to lose its world’s reserve currency status and that it was going basically to zero. And just about any time you start hearing talk like that, you’ve hit the bottom. I don’t know if the US dollar has bottom yet, but it’s definitely in the process of making that argument. The circled candlestick is from the FOMC press conference and that clearly did not weaken the US dollar. We are seeing gold shoot straight up in the air and seeing people talk about de-dollarization because of gold, but both are strengthening. The 1980s had both strengthening, so it doesn’t necessarily mean anything at this point in time. If we were to rally from here, the 1.18 level will offer significant resistance, and that’s assuming that we can even get there, because we’ve tried multiple times over the last two weeks and just haven’t been able to do that. So, with that being said, I think you’ve got a situation where you’re fading rallies at the first signs of exhaustion still.

Ready to trade our daily Forex forecast? Here’s a list of some of the best regulated forex brokers to check out.

Christopher Lewis has been trading Forex and has over 20 years experience in financial markets. Chris has been a regular contributor to Daily Forex since the early days of the site. He writes about Forex for several online publications, including FX Empire, Investing.com, and his own site, aptly named The Trader Guy. Chris favours technical analysis methods to identify his trades and likes to trade equity indices and commodities as well as Forex. He favours a longer-term trading style, and his trades often last for days or weeks.

Source link

9 10, 2025

Digestive Health Supplements Market Poised for Significant

By |2025-10-09T16:28:18+03:00October 9, 2025|Dietary Supplements News, News|0 Comments


Digestive Health Supplements Market Size

The global digestive health supplements market, valued at USD 14.12 billion in 2024, is projected to grow from USD 15.35 billion in 2025 to USD 29.87 billion by 2033, exhibiting a robust CAGR of 8.68% during the forecast period (2025-2033), according to the latest report by Straits Research.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/digestive-health-supplements-market

Digestive health supplements, commonly referred to as nutritional supplements, are increasingly consumed alongside regular diets to enhance digestion and support overall gut health. These supplements aid the body in breaking down carbohydrates, lipids, and proteins, resulting in improved nutrient absorption and digestive function.

The rising prevalence of digestive disorders due to changes in dietary habits and increased consumption of processed and salty foods is driving demand for these supplements worldwide. Beyond digestive health, many of these products also promote immune system support and women’s health, further fueling market expansion.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights : https://straitsresearch.com/report/digestive-health-supplements-market/request-sample

Growth Drivers

One of the primary growth factors in the digestive health supplements market is increasing public awareness of gut health. Consumers are becoming more conscious of the link between digestive wellness, physical health, weight management, and energy levels. The adoption of mobile health apps, wearable fitness trackers, and access to online health resources is empowering individuals to make informed decisions about their dietary habits, creating a strong growth trajectory for the market.

Additionally, the global focus on weight management is contributing to the rise in supplement consumption. Busy lifestyles and reduced physical activity have led to unhealthy BMI levels and obesity, prompting individuals to incorporate supplements that support balanced diets and weight management regimens. Probiotics, in particular, foster beneficial bacteria in the digestive system, promoting overall gut health.

Market Opportunities

Probiotics are emerging as a significant growth opportunity in the digestive health supplements sector. Their affordability, inclusion in functional foods and beverages, and long shelf life make them attractive to consumers. Innovative delivery formats, such as tablets, capsules, and liquids, are further expanding the market reach.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/digestive-health-supplements-market/request-sample

Market Restraints

Despite strong growth potential, the market faces challenges due to stringent regulations. The Supplement Health and Education Act of 1994 mandates companies to ensure that all claims about supplements are accurate and safe. Additionally, firms must comply with FDA registration requirements under the Bioterrorism Act before market introduction. These regulatory requirements, coupled with recent tax increases of 5-10%, may slow market expansion.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/digestive-health-supplements-market

Regional Insights

North America is expected to maintain a leading position in the global digestive health supplements market due to rising demand driven by unhealthy dietary habits and increasing prevalence of obesity and lifestyle-related disorders. Europe is also witnessing steady growth, while the Asia-Pacific region is emerging as a high-demand market, fueled by large populations and expanding product availability in developing countries such as Japan, Australia, and Southeast Asia.

Segment Analysis

The market is segmented by product, form, sales channel, and region. Probiotics are projected to witness the fastest growth due to rising consumer awareness and innovative delivery formats. By form, liquids hold the largest market share, driven by rising health consciousness and demand for nutraceutical syrups. In terms of sales channels, modern trade dominates, though online retailing is expected to record remarkable CAGR over the forecast period.

For more insights and detailed analysis on the Market, visit : https://straitsresearch.com/report/digestive-health-supplements-market/request-sample

Key Players

Organic India

Zenwise

Alimentary Health Limited

Amway

Bayer

Herbalife

NOW Foods

Nature’s Bounty

Nestec SA

Nutricia NV

Garden of Life

HealthForce

Olly

Lonza Group Ltd

Others.

Get your Sample Report to Boost Your Industry Knowledge for Valuable Insights : https://straitsresearch.com/report/digestive-health-supplements-market/request-sample

Report Scope

The Straits Research report covers the market size, revenue forecasts, competitive landscape, growth drivers, regulatory environment, and trends across North America, Europe, Asia-Pacific, the Middle East & Africa, and Latin America. The market is further segmented by product (probiotics, prebiotics, enzymes, and others), forms (capsules, tablets, liquids, and others), and sales channels (modern trade, convenience stores, specialty stores, multi-brand stores, online retailing, and others).

Browse More Insights & Reports

Digestive Health Products Market : https://straitsresearch.com/report/digestive-health-products-market

Detox Products Market : https://straitsresearch.com/report/detox-products-market

Functional Confectionery Market : https://straitsresearch.com/report/functional-confectionery-market

Functional Food Market : https://straitsresearch.com/report/functional-food-market

HT Supplement (50X) Market : https://straitsresearch.com/report/ht-supplement-market

Contact Us

Office 515 A, Amanora Chambers,

Amanora Park Town, Hadapsar,

Pune 411028, Maharashtra, India.

+1 646 905 0080 (U.S.)

+91 8087085354 (India)

+44 203 695 0070 (U.K.)

sales@straitsresearch.com

About Us

For over a decade, Straits Research has been a trusted partner to more than 2,000 small and large enterprises, empowering senior leaders and decision-makers with actionable intelligence to navigate complex markets. Our structured syndicate reports, published year-round, cover critical sectors such as chemicals, materials, food and beverage, healthcare, pharmaceuticals, automotive, technology, aerospace, and defense. Combined with our custom research tailored to client-specific needs, we deliver insights that drive business progress and informed decision-making.

This release was published on openPR.



Source link

9 10, 2025

Dogecoin at $0.25— can Maxi Doge be the meme presale that outshines DOGE’s next surge?

By |2025-10-09T16:03:26+03:00October 9, 2025|Crypto News, News|0 Comments

Dogecoin has finally emerged from the slump it was in over the past few weeks. DOGE tokens regained over 5% in the past few days, bouncing back to the $0.25 price level. However, since Uptober’s rally is still gaining momentum, the latest Dogecoin price prediction anticipates further growth and a potential breakout above $0.49. 

While Dogecoin is driving the expansion of the meme coin market, another dog-inspired project is on the horizon that could outperform it in the upcoming weeks. Its name is Maxi Doge, and it’s the next meme coin that could pump by 100X on release. Let’s compare the two memes in more detail and see why you should add $MAXI tokens to your portfolio before they explode.

Dogecoin Price Prediction – Is DOGE Preparing For a New ATH?

As you already know, Dogecoin is the highest-traded and largest meme coin by total market value. It is often used as a staple for all other memes, and according to the newest Dogecoin price prediction, DOGE is preparing for significant gains in the upcoming weeks. 

After struggling to stay above $0.22 throughout September, Dogecoin has finally gotten the attention of meme coin traders and enthusiasts in October. It rose to $0.27 but has since fallen back to $0.25 due to increased profit-taking. However, it is evident that DOGE can stay above the key support line and is preparing to test the next resistance level at $0.29. The current graph displays a cup-and-handle pattern, indicating that buyers are likely to be in control of upcoming price movements.

If it manages to break through the $0.29 price, Dogecoin could retest its all-time highs of $0.49. In an unlikely outcome where DOGE gathers enough momentum, it could even set a new ATH at $0.65. The most optimistic scenario could lead to a maximum price increase of 150%. The potential of the newest Doge-inspired meme coin, Maxi Doge, surpasses that of Dogecoin by a huge margin. Let’s see why $MAXI tokens are among the hottest meme coins in the past months, and why you should visit the official website to grab yours before the presale sells out.

Maxi Doge – Meme Coin Allowing Users to Trade With 1000X Leverage and No Stop-Loss

As the original meme coin, Dogecoin is a staple for many other projects it has inspired over the years. Maxi Doge is the newest such project on the market, but unlike DOGE, which offers no real-world use cases, $MAXI tokens do offer excellent utility. Although the project’s mascot is everyone’s favorite Doge meme character, Maxi Doge gets value from a crypto-trading feature that allows users to test their skills with 1000X leverage and no stop-loss.

Maxi the dog, the project’s main character, is a satirical depiction of a crypto trader who prioritizes gains in the gym and on the crypto market. He is a crypto trader willing to risk everything to get rich quickly, and if you’re like that too, Maxi Doge could be just the investment option you’ve been looking for.

By investing in $MAXI tokens, you will be able to put your trading skills to the ultimate test. If successful, you can multiply your profits by 1000X, turning a small investment into massive returns. That alone is much more than we can expect from the most optimistic Dogecoin price prediction, which is why you should consider adding $MAXI tokens to your portfolio before it blows up. Visit the official website today and invest in Maxi Tokens early to maximize your profits after the first listings.

Maxi Doge Token Presale Approaching $3 Million Raised

The official $MAXI token presale has been active for several months, raising nearly $3 million to date. It has been one of the best crypto presales in recent months, and it could be the next Doge-inspired project to outperform Dogecoin before the end of the year.

$MAXI tokens are currently selling for $0.000265, but their price will increase with every subsequent stage. If you grab your tokens right now, you can stake them to earn 120% in APY to maximize your rewards before the DEX listing. Visit the Maxi Doge presale today and secure your tokens early, and watch them outperform every Dogecoin price prediction after they go live.

Maxi Doge Will Leave The OG Dogecoin In the Dust – Don’t Miss Your Chance to Invest Early

While the latest Dogecoin price prediction points to future gains for DOGE token holders, the most optimistic outcome is only 150% above its current trading price. That might be good for long-term holders, but if you’re looking to invest right now, DOGE is not the best choice.

Instead, you should grab $MAXI tokens, as they offer superior utility and could help you get 1000X returns on future crypto trades. Visit the Maxi Doge website today, buy $MAXI tokens at a discount, and stake them to maximize your profit even before the first listing. 

Website: https://maxidogetoken.com/

Telegram: https://t.me/maxi_doge

X: https://x.com/MaxiDoge_

News.Az 

Source link

9 10, 2025

Platinum price repeats the positive stability– Forecast today – 9-10-2025

By |2025-10-09T14:29:54+03:00October 9, 2025|Forex News, News|0 Comments


Platinum price repeated providing positive closes in the last period by its stability above $1600.00 level, forming an extra support against the bullish attempts, attempting to settle within the minor bullish channel’s levels by its fluctuating near $1655.00.

 

Note that stochastic attempt to settle within the overbought level might provide extra positive momentum, reinforcing the mission of recording positive stations, which might begin at $1690.00 and $1727.00, while the price decline below the mentioned extra support might force it to provide mixed trading, and there is a chance to decline towards $1665.00 before recording any of the suggested extra targets.

 

The expected trading range for today is between $1600.00 and $1690.00

 

Trend forecast: Bullish





Source link

9 10, 2025

Pound’s rally stalls below 205.00

By |2025-10-09T14:29:40+03:00October 9, 2025|Forex News, News|0 Comments

The British Pound appreciated nearly 3% this week, but the rally seems to be losing momentum on Thursday. The pair has failed to consolidate above 20500 and technical indicators are turning lower, suggesting a potential correction.

The Pound surged on Yen weakness as the victory of Sanae Takaichi in the ruling party’s elections over the weekend, boosted speculation of a looser fiscal policy and dampened expectations of immediate BoJ tightening

Technical analysis: A bearish correction might be ahead

The technical picture shows all the ingredients for a bearish correction. The pair has reached strongly overbought levels at most timeframes, and the 4-Hour Moving Average Convergence Divergence (MACD) has crossed below the signal line, suggesting an increasing bearish pressure.

Bears are pushing against the intraday highs of 204.34 at the time of writing. Further down, the intra-day high at the 203.00 area, and the October 7 low, near 202.10, emerge as the next bearish targets.

To the upside, immediate resistance is at Wednesday’s high of 205.35. Trendline resistance is at 206.15, and the 161.8% Fibonacci retracement of the October 7 – 8 rally is at 207.56.

Japanese Yen Price Today

The table below shows the percentage change of Japanese Yen (JPY) against listed major currencies today. Japanese Yen was the strongest against the British Pound.

USD EUR GBP JPY CAD AUD NZD CHF
USD 0.23% 0.44% 0.28% 0.06% 0.12% 0.45% 0.29%
EUR -0.23% 0.22% 0.07% -0.20% 0.03% 0.24% -0.07%
GBP -0.44% -0.22% -0.18% -0.38% -0.20% 0.06% -0.23%
JPY -0.28% -0.07% 0.18% -0.31% -0.06% 0.13% -0.05%
CAD -0.06% 0.20% 0.38% 0.31% 0.14% 0.41% 0.11%
AUD -0.12% -0.03% 0.20% 0.06% -0.14% 0.29% -0.11%
NZD -0.45% -0.24% -0.06% -0.13% -0.41% -0.29% -0.29%
CHF -0.29% 0.07% 0.23% 0.05% -0.11% 0.11% 0.29%

The heat map shows percentage changes of major currencies against each other. The base currency is picked from the left column, while the quote currency is picked from the top row. For example, if you pick the Japanese Yen from the left column and move along the horizontal line to the US Dollar, the percentage change displayed in the box will represent JPY (base)/USD (quote).

Source link

9 10, 2025

Oatly spotlights speciality teas and global flavours among key beverage trends for years ahead

By |2025-10-09T14:27:49+03:00October 9, 2025|Dietary Supplements News, News|0 Comments


Oatly has launched its first-ever Future of Taste Report, identifying key beverage trends it expects to see in the coming years ahead.

The report was compiled following interviews with hundreds of baristas and drinks experts from across 23 countries, with quantitative trends data compiled by research platform CultureLab.

It identifies five key trends expected on menus and coffee spots in the coming months and years, spotlighting the flavours and formats set to shape future food and beverage culture.

The global flavour exchange

Oatly pointed to data showing that online searches for more exotic ingredients like ube, pandan and hojicha are all on the rise – while ‘matcha mania’ has sparked increasing interest in East and Southeast Asian ingredients within the beverage space. In particular, Oatly said it expects to see more flavours, rituals and traditions from Asia on Western café menus.

Conscious indulgence

Daily google impressions for decaf have grown by 90 times in 2025 according to CultureLab’s data. Oatly predicts the next generation of drinks will continue to focus on balance, with the popularity of decaf and low-sugar beverages set to surge in 2026. This aligns with increasing consumer demand for mindful, health-conscious options.

Fibre ‘coming for protein’s crown’

A social media trend dubbed ‘Fibremaxxing’ spiked this summer after first emerging on TikTok in autumn 2024, encouraging people to increase their daily fibre intake to aid with digestive health and support weight management.

Page views for articles mentioning the term jumped by a staggering 9500% between June-July 2025. At the same time, CultureLab’s data showed that prebiotics are following the same growth pattern and trajectory as protein, which has seen a huge boom in popularity within functional food formulations in recent years, suggesting gut health will continue to surge further into the mainstream.

Oatly expects this will result in the development of more products with fibre-packed ingredients like chia seeds, as well as fermented offerings, with drinks like Tepache – a centuries-old Mexican beverage made with fermented pineapple – poised to grow in popularity around the world.

Destination drinks

As globalisation is creating a landscape where the same menus appear in different cities, Oatly said that creative offerings invented and sold exclusively by a particular café are booming in popularity.

As a result, unique local ingredients – such as Australian lemon myrtle and pepperberries, or Finnish forest berries – will become ‘cultural currency’ for a generation hooked on novelty, the alt-milk maker predicted.

With 85% of baristas agreeing that consumer tastes are becoming more adventurous, the report identified provenance and distinctiveness as USPs setting signature drink offerings apart.

Matcha and beyond

The rise in matcha has shown no signs of slowing, but Oatly pointed out that it may have reached its peak – though the jury is still out, emerging consensus suggests it has staying power, the brand noted.

However, some baristas already look to be lining up innovative new speciality tea offerings with potential to become the next big trend. Earl Grey was under the spotlight in cocktails and drinks in the US earlier this year, while oolong and jasmine varieties from China are rising in popularity and specialised milk tea shops are popping up across Shanghai.

In the UK, the report findings have been backed by data from Censuswide’s poll of 2000 consumers, commissioned by Oatly.

When asked which of the new flavours mentioned in the report British consumers would most like to try, lemon myrtle (24%) and pepperberry (19%) came out ahead of matcha (16%) and black sesame (14%).

Despite the rising global popularity, over a third (35%) of UK consumers are yet to try any of the new wave of Asian-inspired ingredients, with just 3% having sampled shiso and 4% trying pandan in the past 12 months.

The research also showed that just over six in ten Brits (61%) have already cut back or considered cutting back on caffeine, particularly men (62%). When asked what they’d swap coffee out for, green tea (34%) and decaf coffee (32%) led the way, with a third of Gen Z (33%) selecting matcha as their slow-release caffeine fix.

Over half (54%) said TikTok’s ‘fibremaxxing’ trend or the growing focus on fibre has influenced them, with millennials the most likely (28%) to be actively increasing their fibre intake.

Rowena Roos, Oatly global head of food and drinks experience, said: “This report paints a vibrant picture of where beverage trends are heading. People’s daily drink choices, especially younger generations, are being shaped by a world in flux. We’re seeing drink trends go viral from London to Seoul, and technology is making it easier to order, customise and share these signature moments.”

She added: “Health, sustainability trends and global flavours are all blending as a generation raised online is seeking both identity and connection in every cup. At Oatly, we’re working with coffee and hospitality partners to turn these global taste trends into incredible on-menu experiences.”



Source link

9 10, 2025

ADA Holders In For A Shock As Price Expected To Dump Under $0.20 Next Year

By |2025-10-09T14:02:03+03:00October 9, 2025|Crypto News, News|0 Comments

Disclaimer: This is a Press Release provided by a third party who is responsible for the content. Please conduct your own research before taking any action based on the content.


The Cardano price prediction for 2025 is sparking concern among holders as on-chain data points to growing selling pressure. After months of steady trading, ADA’s long-term outlook is now in jeopardy as liquidity wanes and momentum dissipates in the altcoin market.

Cardano has established a strong foundation through its staking system and smart contract platform, but its native coin may experience one of the worst drops in years if ongoing market trends persist. Investors are growing increasingly conservative, looking instead to newer crypto projects that offer more solid real-world uses, like Remittix (RTX). 

ADA Market Performance and Key Metrics

At the time of writing, Cardano (ADA) trades at $0.8490, recording a 0.72% increase in the past 24 hours. Its market capitalization is $30.7 billion, while daily trading volume has risen by 30.62% to $1.49 billion.

Despite these positive short-term developments, analysts remain cautious about ADA’s long-term prospects. Technical indicators indicate weakening support zones, and whale activity has been shifting toward DeFi-focused assets and low-gas-fee crypto alternatives.

ADA Holders In For A Shock As Price Expected To Dump Under alt=

This trend has revived discussions about whether ADA can maintain its market position through 2025. Some forecasts now suggest that the Cardano price could fall below $0.20 next year if network activity and liquidity continue to slow. As market sentiment softens, ADA may struggle to attract new capital compared to emerging projects building toward faster adoption.



Remittix: The DeFi Project Gaining Global Traction

As ADA holders reassess their strategies, Remittix (RTX) is standing out as a promising DeFi project with real-world functionality. Priced at $0.1130 per token, Remittix has raised over $27.2 million in its presale, with 676 million tokens sold to date.

The project enables users to send crypto directly to bank accounts in 30+ countries, positioning itself as one of the top crypto under $1 offering real utility.

The Remittix team is now verified by CertiK and ranked #1 for pre-launch tokens, reinforcing its credibility. The project has also revealed future listings on BitMart and LBank, signaling strong exchange partnerships ahead of launch. With beta testing now live for the Remittix Wallet, users are already exploring its payment features — a significant step toward full-scale adoption.

What’s Driving Remittix Momentum:

  • Crypto-to-bank transfers in over 30 countries
  • $27.2M+ raised and 676M tokens sold
  • Ranked #1 pre-launch token on CertiK
  • Future listings confirmed on BitMart and LBank
  • $250,000 Giveaway and 15% referral rewards live at remittix.io

Market Shift Could Reshape 2025

The Cardano prediction signals growing caution among traditional altcoin holders, as investor focus turns toward crypto solving real-world problems. Remittix exemplifies this transition, combining DeFi infrastructure with practical payments and scalable growth potential.

While ADA’s long-term strength depends on network revival, newer entrants like Remittix show how real-world integration may define the next big altcoin of 2025. For now, investors tracking the best crypto presale of 2025 are watching RTX closely — a token that bridges utility, accessibility, and trust in a rapidly changing market.

Discover the future of PayFi with Remittix by checking out their project here:
Website: https://remittix.io/
Socials: https://linktr.ee/remittix
$250,000 Giveaway: https://gleam.io/competitions/nz84L-250000-remittix-giveaway

Disclaimer: This media platform provides the content of this article on an “as-is” basis, without any warranties or representations of any kind, express or implied. We assume no responsibility for any inaccuracies, errors, or omissions. We do not assume any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information presented herein. Any concerns, complaints, or copyright issues related to this article should be directed to the content provider mentioned above.

/div>

Source link

Go to Top